Home
Guidelines
Pathogens
Antimicrobials
Oral inhalation
Minimal absorption of orally inhaled drug suggests no dose adjustment.
Consult product monograph for updated information in relation to drug exposure based on type of delivery device.
More Common
Diarrhea
Vomiting
Nausea
Less Common
Dizziness
Syncope with inhalation
Reports of abnormal behaviour similar to oseltamivir and peramivir (limited experience to date).
Long-acting
Approved in Japan since 2010
Not yet approved in North America.